期刊文献+

RNA干扰下调Slug表达对肺癌细胞A549的细胞周期、增殖和侵袭的影响 被引量:1

Effect of down-regulation of the Slug gene expression by RNAi on cell cycle, proliferation and invasion of lung cancer A549 cells
下载PDF
导出
摘要 目的:应用RNA干扰技术下调肺癌A549细胞中Slug基因的表达,探讨其对A549细胞增殖、细胞周期和细胞侵袭能力的影响。方法:构建靶向Slug基因的shRNA真核表达质粒pGPU6-GFP-Neo-Slug,与阴性对照质粒pNeg-shRNA分别用脂质体法转染A549细胞。Real-time PCR和Western blotting验证转染后Slug mRNA和蛋白的表达。CCK-8法、流式细胞术和Transwell实验分别检测下调Slug表达对A549细胞增殖、细胞周期和侵袭能力的影响。结果:成功构建pGPU6-GFP-NeoSlug载体并转染A549细胞,转染率达90%。与pNeg-shRNA组和空白对照组相比,pSlug-shRNA组A549细胞中Slug mRNA[(0.23±0.01)vs(0.97±0.08)、(1.0±0.09),P<0.05]和蛋白[(0.20±0.09)vs(1.0±0.32)、(1.13±0.26),P<0.05]表达量显著降低;细胞增殖抑制率明显上升[(35.3±5.4)%vs(1.5±0.2)%、(3.3±0.7)%,均P<0.01];细胞增殖指数显著降低[(32.92±0.69)%vs(48.19±0.71)%、(42.88±0.75)%,均P<0.05],并且处于G1期细胞数明显增多[(67.08±0.92)%vs(52.81±0.78)%、(56.12±0.73)%,均P<0.05];细胞侵袭能力显著降低[穿透基底膜细胞数:(55±9)vs(169±12)、(173±15),均P<0.01]。结论:pGPU6-GFP-Neo-Slug转染肺癌A549细胞能有效下调Slug基因的表达,从而抑制A549的增殖侵袭能力、阻滞细胞周期于G1期。 Objective: To study the effect of silencing Slug gene on proliferation, cell cycle and invasion ability of lung cancer A549 cells by RNA interference technique. Methods: The recombinant plasmid expressing short hairpin RNA (shRNA) targeting Slug gene was constructed and named as pGPU6-GFP-Neo-Slug. A549 cells were transfected with pGPU6-GFP-Neo-Slug and the negative control plasmid pNeg-shRNA with liposome method. Real-time PCR and Western blotting analysis was performed to determine the expression of Slug mRNA and protein after transfection, respectively. The proliferation, cell cycle distribution and cell invasion of A549 cells were detected by CCK-8 assay, flow cytometry and tr answell assay, respectively. Results: pGPU6-GFP-Neo-Slug vector was successfully constructed and transfected into A549 cells with transfection rate of nearly 90%. Compared to the control and pNeg-shRNA group, Slug mRNA ( [0.23 ±0.011 vs [0.97 +0.08], [1.0±0.09] ; all P 〈0.05) and protein ([0.20 ±0.09] vs [ 1.0±0.32], [ 1.13±0.26] ; all P 〈 0.05) expression level was significantly reduced in pSlug-shRNA group. Compared to the control and pNeg-shRNA group, the inhibition rate of proliferation in Slug-silencing A549 cells was significantly increased ( [ 35.3 + 5.4 ] % vs [ 1.5 ± 0.2% ], [ 3.3 ±0.7% ] ; all P 〈 0.05 ) ; the cell multiplication index was significantly decreased ( [ 32.92± 0. 69] vs [48.19 ±0.71 ], [42.88 ±0.75] ; all P 〈0.05) ; the cell number in G1 phase was significantly increased( [ 67.08 ± 0. 92 ] vs [ 52.81 ± 0.78 ], [ 56.12 ± 0.73 ] ; all P 〈 0.05 ) ; and the cell invasion ability of A549 was signifi- cantly reduced ( number of alive A549 cells through the matrigel chamber: [ 55 ± 9 ] vs [ 169 ± 121, [ 173 ± 15 ] ; all P 〈 0.01 ). Conclusion: pGPU6-GFP-Neo-Slug vector transfected into lung cancer A549 cell can effectively silence Slug gene expression, inhibit cell proliferation, influence cell cycle and inhibit cell invasion of A549 cells.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2013年第6期685-689,共5页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.81102057)~~
关键词 RNA干扰 SLUG基因 肺癌 A549细胞 增殖 细胞周期 侵袭 RNA interference Slug gene lung cancer A549 cell proliferation cell cycle invasion
  • 相关文献

参考文献1

二级参考文献12

  • 1Walker W S,Pugh G C,Craig S R,et al.Continued experience with thoracoscopic major pulmonary resection[J].Int Surg,1996,81(3):255-258.
  • 2Demmy T L,Curtis J J.Minimally invasion lobectomy directed toward frail and high-risk patients:a case control study[J].Ann Thorac Surg,1999,68 (1):194-200.
  • 3Nagahiro I,Andou A,Aoe M,et al.Pulmonary function,postoperative pain,and serum cytokine level after lobectomy:a comparison of vats and conventional procedure[J].Ann Thorac Surg,2001,72(2):362-365.
  • 4Kaseda S,Aoki T,Hangai N,et al.Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy[J].Ann Thorac Surg,2000,70(5):1644-1646.
  • 5Sugi K,Kaneda Y,Esato K.Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage Ⅰ A lung cancer[J].World J Surg,2000,24(1):27-30.
  • 6Karnofsky D A,Burchenal J H.Evaluation of chemotherapeutic agents[M]// Macload C M,ed.The Clinical Evaluation of Chemotherapeutic Agents in Cancer.New York:Columbia U.Press,1949:191-205.
  • 7Priestman T J,Baum M.Evaluation of quality of life in patients receiving treatment for advanced breast cancer[J].Lancet,1976,1 (7965):899-900.
  • 8Schipper H,Clinch J,McMurray A,et al.Measuring the quality of life of cancer patients:the Functional Living IndexCancer:development and validation[J].J Clin Oncol,1984,2 (5):472-483.
  • 9Sugiura H,Morikawa T,Kaji M,et al.Long-term benefits for the quality of life after video-assisted thoracoscopic lobectomy in patients with lung cancer[J].Surg Laparosc Endosc Percutan Tech,1999,9(6):403-408.
  • 10Li W W,Lee T W,Lam S S,et al.Quality of life following lung cancer resection:video-assisted thoracic surgery vs thoracotomy[J].Chest,2002,122(2):584-589.

共引文献31

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部